INFLAMMASOMES AND INFLAMMATION

Cover Page
  • Authors: Garib F.Y.1,2,3, Rizopulu A.P.4
  • Affiliations:
    1. Russian Medical Academy of Сontinuing Professional Education
    2. M. V. Lomonosov Moscow State University
    3. I.M. Sechenov First Moscow State Medical University
    4. The State Duma of Russian Federation
  • Issue: Vol 20, No 4 (2017)
  • Pages: 30-36
  • Section: REVIEWS
  • Submitted: 17.04.2020
  • Accepted: 17.04.2020
  • Published: 15.10.2017
  • URL: https://rusimmun.ru/jour/article/view/106
  • ID: 106

Cite item

Full Text

Abstract

The formation of multimolecular complex: inflammasome is a platform for caspases’ activation, which process proinflammatory cytokines into biologically active forms (IL­1 and IL­18). Their secretion initiate and maintain the inflammation. Inflammasome activation is able to trigger the pyroptosis in the infected host cells in order to eliminate microbial pathogens.

About the authors

F. Yu. Garib

Russian Medical Academy of Сontinuing Professional Education; M. V. Lomonosov Moscow State University; I.M. Sechenov First Moscow State Medical University

Author for correspondence.
Email: fgarib@yandex.ru

PhD, MD (Medicine), professor, the Department of Immunology; Biological Faculty, the Department of Immunology, Professor; Professor the Department of Clinical Immunology and Allergolody

125993, Moscow, Barrikadnay str., 2/1, 1

Russian Federation

A. P. Rizopulu

The State Duma of Russian Federation

Email: fake@neicon.ru

PhD, MD (Biology)

Moscow

Russian Federation

References

  1. Janewey C. A., Jr Frontiers of the immune system. Nature, 1988, 333, 804.
  2. Medzhitov R. in Fundamental Immunol (Paul, W.E., ed.), Lippincott Williams and Wilkins 2008, pp. 427-450.
  3. Kumar H., Kawai T., Akira S. Pathogen recognition in the innate immune response. Biochem. J. 2009, 420, 1-16.
  4. Janeway’s immunobiology, 9 th edition (Murphy, K.; Weaver, C. eds.), New York, NY: Garland Science/ Taylor & Francis Group, LLC, Edition/Format, 2017, pp 35-54.
  5. Matzinger P. The danger model: a renewed sense of self. Science, 2002, 296, 301-305.
  6. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140, 805-820.
  7. Kanneganti T. D., Lamkanfi M., Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 2007, 27, 549-559.
  8. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140(6), 821-832.
  9. Недоспасов С. А. Врожденный иммунитет и его механизмы, Москва, Научный мир, 2012, 21-23.
  10. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proILbeta. Mol. Cell. 2002, 10, 2, 417-426.
  11. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 2009, 27, 229-265.
  12. Alnemri E. S. Sensing cytoplasmic danger signals by the inflammasome. J. Clin. Immunol. 2010, 30, 4, 512-519.
  13. Franchi L., Amer A., Body-Malapel M., Kanneganti T. D., Ozören N., Jagirdar R., Inohara N., Vandenabeele P., Bertin J., Coyle A., Grant E. P., Núñez G. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1b in salmonella-infected macrophages. Nat. Immunol. 2006, 7, 6, 576-582.
  14. Callus B. A., Vaux D. L. Caspase inhibitors: viral, cellular and chemical. Cell death and differentiation 2007, 14, 73-78.
  15. Ulland T. K., Ferguson P. J., Sutterwala F. S. Evasion of inflammasome activation by microbial pathogens. The Journal of Clinical Investigation 2015, 125, 2, 469-477. doi: 10.1172/JCI75254.
  16. Elinav E., Strowig T., Kau A. L., Henao-Mejia J., Thaiss C. A., Booth C. J., Peaper D. R., Bertin J., Eisenbarth S. C., Gordon J. I., Flavell R. A. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145(5), 745-757. doi: 10.1016/j.cell.2011.04.022. Epub 2011 May 12.
  17. Khare S., Dorfleutner, A., Bryan N. B., Yun C., Radian A. D., de Almeida L., Rojanasakul Y., Stehlik C. An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. Immunity 2012, 36(3), 464-476. doi: 10.1016/j.immuni.2012.02.001. Epub 2012 Feb 21.
  18. Poeck H., Bscheider M., Gross O., Finger K., Roth S., Rebsamen M., Hannesschläger N., Schlee M., Rothenfusser S., Barchet W., Kato H., Akira S., Inoue S., Endres S., Peschel C., Hartmann G., Hornung V., Ruland J. Recognition of RNA virus by RIG-I results in activation of CARD 9 and inflammasome signaling for interleukin 1β production. Nat Immunol. 2010, 11(1), 63-69. doi: 10.1038/ni.1824.
  19. Petrilli V., Papin S., Dostert C., Mayor A., Martinon F., Tschopp J. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell. Death Differ. 2007, 14, 9, 1583-1589.
  20. Faustin B., Lartigue L., Bruey J. M., Luciano F., Sergienko E., Bailly-Maitre B., Volkmann N., Hanein D., Rouiller I., Reed J. C. Reconstituted NALP1 inflammasome reveals two-stepmechanismofcaspase-1 activation. Mol. Cell 2007, 25, 5, 713-724.
  21. Vladimer G. I., Marty-Roix R., Ghosh S., Weng D., Lien E. Inflammasomes and host defenses against bacterial infections. Curr Opin Microbiol. 2013, 16(1), 23-31.
  22. Lupfer C., Kanneganti T. D. The expanding role of NLRs in antiviral immunity. Immunol Rev. 2013, 255(1), 13-24.
  23. Joly S., Sutterwala F. S. Fungal pathogen recognition by the NLRP3 inflammasome. Virulence 2010, 1(4), 276-280.
  24. Clay G. M., Sutterwala F. S., Wilson M. E. NLR proteins parasitic disease. Immunol Res. 2014, 59(1-3), 142-152.
  25. Kanneganti T. D., Ozoren N., Body-Malapel M. Amer A., Park J. H., Franchi L., Whitfield J., Barchet W., Colonna M., Vandenabeele P., Bertin J., Coyle A., Grant E. P., Akira S., Nunez G. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006, 440(7081), 233-236.
  26. Allen I. C., Scull M. A., Moore C. B., Holl E. K., Mcelvania-Tekippe E., Taxman D. J., Guthrie E. H., Pickles R. J., Ting J. P. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009, 30, 556-565.
  27. Ghiringhelli F., Apetoh L., Tesniere A., Aymeric L., Ma Y., Ortiz C., Vermaelen K., Panaretakis T., Mignot G., Ullrich E., Perfettini J. L., Schlemmer F., Tasdemir E., Uhl M., Génin P., Civas A., Ryffel B., Kanellopoulos J., Tschopp J., André F., Lidereau R., McLaughlin N.M., Haynes N. M., Smyth M. J., Kroemer G., Zitvogel L. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009, 15(10), 1170-1178. doi: 10.1038/nm.2028. Epub 2009 Sep 20.
  28. Sutterwala F. S., Haasken S., Cassel S. L. Mechanism of NLRP3 inflammasome activation. Ann NYAcad Sci. 2014, 1319(1), 82-95.
  29. Nakahira K., Haspel J. A., Rathinam V. A., Lee S. J., Dolinay T., Lam H. C., Englert J. A., Rabinovitch M., Cernadas M., Kim H. P., Fitzgerald K. A., Ryter S. W., Choi A. M. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2011, 12, 222-230.
  30. Besnard A. G., Guillou N., Tschopp J., Erard F., Couillin I., Iwakura Y., Quesniaux V., Ryffel B., Togbe D. NLRP3 inflammasome is required in murine asthma in the absence of aluminum adjuvant. Allergy 2011, 66, 1047-1057.
  31. Thomas P. G., Dash P., Aldridge Jr, J.R., Ellebedy A. H., C. Reynolds, Funk, A.J., Martin W. J., Lamkanfi M., Webby R. J., Boyd K. L., Doherty P. C., Kanneganti T. D. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 2009, 30, 4, 566-575. doi: 10.1016/j.immuni.2009.02.006. Epub 2009 Apr 9.
  32. Gong Y. N., Shao F. Sensing bacterial infections by NAIP receptorsin NLRC 4 inflammasome activation, Protein Cell 2012, 3(2), 98-105.
  33. Miao E. A., Warren S. E. Innate Immune Detectionof Bacterial Virulence Factors ViatheNLRC 4 Inflammasome. J. Clin. Immunol. 2010, 30, 4, 502-506.
  34. Lamkanfi M., Dixit V. M. Mechanisms and functions of inflammasomes, Cell 2014, 157(5), 1013-1022.
  35. Schattgen S. A., Fitzgerald K. A. The PYHIN protein family as mediators of host defenses. Immunol Rev. 2011, 243(1), 109-118.
  36. Man S. M., Karki R., Kanneganti T. D. AIM2 inflammasome in infection, cancer, and autoimmunity: Role in DNA sensing, inflammation, and innate immunity. Eur. J. Immunol. 2016, 46, 2, 269-280. doi: 10.1002/eji.201545839.
  37. Arend W. P., Palmer G., Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev. 2008, 223, 20-38. doi: 10.1111/j.1600-065X.2008.00624.
  38. Miao E. A., Leaf I. A., Treuting P. M., Mao D. P., Dors M., Sarkar A., Warren S. E., Wewers M. D., Aderem A. Caspase-1-induced pyroptosisis an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 2010, 11, 1136-1142.
  39. Gu Y. Kuida K., Tsutsui H., Ku G., Hsiao K., Fleming M. A., Hayashi N., Higashino K., Okamura H., Nakanishi K., Kurimoto M., Tanimoto T., Flavell R. A., Sato V., Harding M. W., Livingston D. J., Su M. S. Activation of interferon-ginducing factormediated by interleukin-1b converting enzyme. Science 1997, 275(5297), 206-209.
  40. Ghayur T., Banerjee S., Hugunin M., Butler D., Herzog L., Carter A., Quintal L., Sekut L., Talanian R., Paskind M., Wong W., Kamen R., Tracey D., Allen H. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature, 1997, 386(6625), 619-623.
  41. Dinarello C. A. Immunological and inflammatory functions of theinterleukin-1 family. Annu. Rev. Immunol. 2009, 27, 519-550.
  42. Weaver C. T., Harrington L. E., Mangan P. R., Gavrieli M., Murphy K. M. Th17: an effector CD 4 T cell lineage with regulatory T cell ties. Immunity 2006, 24,677-688.
  43. Harrington L. E., Hatton R.D, Mangan P. R., Turner H., Murphy T. L., Murphy K. M., Weaver C. T. Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6, 1123-1132.
  44. Man S. M., Kanneganti T. D. Regulation of inflammasome activation. Immunol Rev. 2015, 265(1), 6-21. doi: 10.1111/imr.12296.
  45. Abdullah Z., Knolle P. A. Scaling of immune responses against intracellular bacterial infection. The EMBO J. 2014, 33 (20), 2283-2294.
  46. Guo H., Callaway J. B., Ting J. P. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015, 21(7), 677-687. doi: 10.1038/nm.3893. Epub 2015 Jun 29.
  47. Гариб Ф. Ю., Ризопулу А. П., Кучмий А. А., Гариб В. Ф. Инактивация инфламмасом патогенами регулирует воспаление. Биохимия 2016, 81, 11, 1578-1592.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Garib F.Y., Rizopulu A.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies